Cargando…
Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein
BACKGROUND: Human papillomavirus type 16 (HPV16) infection is implicated in cervical carcinogenesis. This study aimed to characterize two new monoclonal antibodies (mAbs) against HPV L1 protein. METHODS: The immunocompetence of AE3 and AG7 mAbs for HPV L1 protein was evaluated by Western blot analys...
Autores principales: | Wang, Yan, Shang, Qinglong, Xu, Weizhen, Li, Di, Gu, Hongxi, Wei, Lanlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099146/ https://www.ncbi.nlm.nih.gov/pubmed/24884993 http://dx.doi.org/10.1186/1746-1596-9-101 |
Ejemplares similares
-
Interleukin-12 gene adjuvant increases the immunogenicity of virus-like particles of human papillomavirus type 16 regional variant strain
por: Wei, Lanlan, et al.
Publicado: (2013) -
Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16
por: Verachi, F., et al.
Publicado: (2018) -
Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein
por: Togtema, Melissa, et al.
Publicado: (2019) -
Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003) -
Detection of Human Antibody against the Human Papillomavirus Type 16 E7 Protein
por: Hashido, Madoka, et al.
Publicado: (1991)